Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma

Journal of Virological Methods

Volumn 127, Issue 1, 2005, Pages 54-59

  De Mendoza, C ^a   Koppelman, M ^b   Montes B ^c   Ferre, V ^d   Soriano, V ^a   Cuypers, H ^b   Segondy, M ^c   Oosterlaken, T ^e  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRAL LABORATORY   (Netherlands)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e BIOMÉRIEUX   (France)

Author keywords

HIV RNA; Non B subtypes; Real time PCR; Viral load

Indexed keywords

VIRUS RNA;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; METHODOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS DETECTION; VIRUS LOAD;

FRANCE; HIV INFECTIONS; HIV-1; HUMANS; NETHERLANDS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPAIN; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18944362911     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.03.013     Document Type: Article

References (27)

1. A. Alaeus, K. Lidman, A. Sonnenborg, and J. Albert Subtype specific problems with quantification of plasma HIV-1 RNA AIDS 11 1997 859 865
2. J. Bland, and D. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
3. D.J. Brambilla, S. Granger, C. Jennings, and J.W. Bremer Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche Amplicor HIV-1 Monitor assays J. Clin. Microbiol. 39 2001 1121 1123
4. E. Connick, M. Lederman, B. Kotzin, J. Spritzler, D. Kuritzkes, M. St Clair, A. Sevin, L. Fox, M. Chiozzi, J. Leonard, F. Rousseau, J. D'Arc Roe, A. Martinez, H. Kessler, and A. Landay Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response J. Infect. Dis. 181 2000 358 363
5. C. De Mendoza, A. Holguin, and V. Soriano False positives for HIV using commercial viral load quantification assays AIDS 12 1998 2076 2077
6. J.R. Dyer, C.D. Pilcher, R. Shepard, J. Schock, J.J. Eron, and S.A. Fiscus J. Clin. Microbiol. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of HIV type 1 RNA in plasma 37 1999 447 449
7. A. Erice, D. Brambilla, J. Bremer, J.B. Jackson, R. Kokka, B. Yen-Lieberman, and R. Coombs Performance characteristics of the Quantiplex HIV-1 RNA 3.0 assay for detection and quantitation of HIV type 1 RNA in plasma J. Clin. Microbiol. 38 2000 2837 2845
8. J.E. Gallant Strategies for long-term success in the treatment of HIV infection JAMA 283 2000 1329 1334
9. C. Ginocchio, M. Kemper, K.A. Stellrecht, and D. Witt Multicenter evaluation of the performance characterisitics of the Nuclisens HIV-1 QT assay used for quantitation of HIV-1 RNA J. Clin. Microbiol. 41 2003 164 173
10. G.J. Hanna, H.U. Balaguera, K.A. Freedberg, B.G. Werner, K.A. Steger Crav, D.E. Craven, and R. D'Aquila Drug-selected mutations and non-B subtypes in antiretroviral-naive adults with established HIV infection J. Infect. Dis. 188 2003 986 991
11. D.H. Havlichek, and E. Hage-Korban False-positive HIV diagnosis by HIV-1 plasma viral load testing Ann. Int. Med. 131 1999 37 39
12. D.V. Havlir, N.S. Hellmann, C.J. Petropoulos, J.M. Whitcomb, A.C. Collier, M.S. Hirsch, P. Tebas, J.P. Sommadossi, and D.D. Richman Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens JAMA 283 2000 229 233
13. A. Holguín, A. Alvarez, M.J. Pena, F. Artiles, L. Molina, and V. Soriano HIV-positive immigrants in the Canary Islands Spain: implications for public health in Europe HIV Clin. Trials 4 2003 184 192
14. E. Jenny-Avital, and S. Beatrice Erroneously low or undetectable plasma HIV-1 RNA load, determined by PCR, in West African and American patients with non-B subtype HIV-1 infection Clin. Infect. Dis. 32 2001 1227 1230
15. I. Loussert-Ajaka, D. Descamps, F. Simon, F. Brun-Vézinet, M. Ekwalanga, and S. Sarogosti Genetic diversity and HIV detection by polymerase chain reaction Lancet 346 1995 912 913
16. D.G. Murphy, L. Côté, M. Fauvel, P. René, and J. Vincelette Multicenter comparison of Roche Cobas Amplicor Monitor version 1.5, Organon-Teknika Nuclisens QT with extractor, and Bayer Quantiplex version 3.0 for quantification of HIV type 1 RNA in plasma J. Clin. Microbiol. 38 2000 4034 4041
17. F.S. Nolte, J. Boysza, C. Thurmond, W.S. Clark, and J.L. Lennox Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of HIV type 1 RNA in plasma J. Clin. Microbiol. 36 1998 716 720
18. J.V. Parry, G. Murphy, K. Barlow, K. Lewis, P. Rogers, F. Belda, A. Nicoll, C. McGarrigle, S. Cliffe, P. Mortimer, and J. Clewley National surveillance of HIV-1 subtypes for England and Wales J. Acquir. Immun. Def. Syndr. 26 2001 381 388
19. A. Pozniak, B. Gazzard, J. Anderson, A. Babiker, D. Churchill, M. Collins, M. Fisher, M. Johnson, S. Khoo, C. Leen, C. Loveday, G. Moyle, M. Nelson, B. Peter, A. Phillips, D. Pillay, E. Wilkins, and M. Youle BHIVA Writing Committee BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy HIV Med. 4 2003 1 41
20. J.M. Raboud, J.S. Montaner, B. Conway, S. Rae, P. Reiss, S. Vella, D. Cooper, J. Lange, M. Harris, M.A. Wainberg, P. Robinson, M. Myers, and D. Hall Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy AIDS 12 1998 1619 1624
21. R. Sun, J. Ku, H. Jayakar, J.C. Kuo, D. Brambilla, S. Herman, M. Rosenstraus, and S. Spadoro Ultrasensitive reverse transcription-PCR assay for quantitation of HIV type 1 RNA in plasma J. Clin. Microbiol. 36 1998 2964 2969
22. K. Triques, J. Coste, J.L. Perret, C. Segarra, E. Mpoudi, J. Reynes, E. Delaporte, A. Butcher, K. Dreyer, S. Herman, J. Spadoro, and M. Peeters Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of HIV type 1 J. Clin. Microbiol. 37 1999 110 116
23. S. Tyagi, and F.R. Kramer Molecular beacons: probes that fluoresce upon hybridisation Nat. Biotechnol. 14 1996 303 308
24. R. Van Beuningen Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons R. Raghavachari W. Tan Genomics and Proteonomics Technologies, Proceedings of the SPIE 2001 Society of Photo-optical Instrumentation Engineers Washington, DC 66 72
25. A.M. Vandamme, J.S. Schmit, S. Van Dooren, K. Van Laethem, E. Gobbers, W. Kok, P. Goubau, M. Witvrouw, W. Peetermans, E. De Clerq, and J. Desmyter Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor test J. Acquir. Immun. Def. Syndr. 13 1996 127 139
26. J.J. Weusten, W.M. Carpay, T. Oosterlaken, M. van Zuijlen, and P. Van de Wiel Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons Nucl. Acids Res. 30 2002 e26
27. P. Yeni, S. Hammer, M. Hirsch, M. Saag, M. Schechter, C. Carpenter, M. Fischl, J. Gatell, B. Gazzard, D. Jacobsen, D. Katzenstein, J. Montaner, D. Richman, R. Schooley, M. Thompson, S. Vella, and P. Volberding Treatment for adult HIV infection 2004 Recommendations of the International AIDS Society-USA Panel JAMA 292 2004 251 265